Pharmaids Pharmaceuticals share news and announcements

BSE: 524572Pharmaceuticals & BiotechnologySmall Cap

₹28.92₹0.63 (2.23%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹28.29.

52-week range of traded prices to 23 Oct 2026

₹25.60Low, 1 Jun 2026₹53.90High, 9 Dec 2025

Market cap: ₹102 Cr2,774th largest listed
P/E: Lossover the last 12 months
P/B: 2.1
Dividend yield: Nonein the last 12 months
ROE: −8.5%
ROE without one-offs: −21.1%
ROCE: −15.8%
Debt to equity: 0.44
Volume, BSE: 1,482

Pharmaids Pharmaceuticals share news and announcements

617 announcements, routine notices left out, newest first. Page 6 of 13.

Feb 2023
- 3 Feb · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve the un-audited financial .... (opens in a new tab)
Jan 2023
Dec 2022
- 31 Dec · Meeting
  Dear Sir/Madam Please find the enclosed outcome of the 1st Extraordinary General Meeting for the Financial Year 2022-23 held today i.e. 31st December, 2022 for dissemination. Regards For .... (opens in a new tab)
- 7 Dec · Meeting
  EGM to be held on December 31, 2022 At 12.00 Noon - Uploading of EGM Notice, as dispatched to the shareholders today. (opens in a new tab)
- 6 Dec · Board meeting
  Dear Sir/Madam, Outcome of the Board Meeting held on 06.12.2022 for Conversion of Share Warrants and allotment of Equity shares pursuant to the Conversion, Convening of the EGM and other .... (opens in a new tab)
- 1 Dec · Board meeting
  Meeting on 6 Dec 2022
- 1 Dec · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/12/2022 ,inter alia, to consider and approve Calling of 1st Extraordinary .... (opens in a new tab)
- 1 Dec · Board meeting
  Revised outcome of the Board Meeting held on 29.11.2022 (opens in a new tab)
Nov 2022
- 29 Nov · Board meeting
  Submission of Outcome of the Board Meeting held on 29.11.2022 for consideration and approval of the Preferential Issue and other related matters. (opens in a new tab)
- 24 Nov · Regulation 23(9)- Disclosure Of Related Party Transaction
  Regulation 23(9)- Disclosure of Related Party Transaction for the half year ended September, 2022 (opens in a new tab)
- 23 Nov · Board meeting
  Meeting on 29 Nov 2022: preferential issue of shares
- 23 Nov · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/11/2022 ,inter alia, to consider and approve To consider appointment .... (opens in a new tab)
- 23 Nov · Results
  Please find attached the Financials along with the corrected Limited Review Report, being re-submitted, as advised, for your perusal. (opens in a new tab)
- 10 Nov · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR')
  Receipt of Order from Regional Director (South East Region), Hyderabad for shifting of Registered Office from State of Telangana to State of Karnataka (opens in a new tab)
- 9 Nov · Results
  Please find attached the Unaudited Financial Results along with the Limited Review Report for the Quarter and Half-Year ended September 30, 2022 (opens in a new tab)
- 2 Nov · Board meeting
  Meeting on 9 Nov 2022: quarterly results
- 2 Nov · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve Board Meeting to .... (opens in a new tab)
Oct 2022
- 31 Oct · Management
  Outcome of Board Meeting and under Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') (opens in a new tab)
- 13 Oct · Management
  Mr. Chilam Srikanth has resigned from the post of Chief Financial Officer w.e.f. 13.10.2022. In his place, the Board has appointed Mr. Balagangadhara B C as the Chief Financial Officer .... (opens in a new tab)
- 13 Oct · Management
  Appointment of Mr. Kaushik Kumar as the Company Secretary and Compliance Officer w.e.f 13.10.2022 in place of Ms. Annie Jodhani who has resigned as CS and Compliance Officer w.e.f 13.10.2022 (opens in a new tab)
- 13 Oct · Board meeting
  Allotment of Equity share warrants on Preferential basis (opens in a new tab)
- 8 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 7 Oct · Board meeting
  Meeting on 13 Oct 2022: issue of warrants
- 7 Oct · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2022 ,inter alia, to consider and approve and allot 54,00,000 .... (opens in a new tab)
Aug 2022
- 23 Aug · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/524572 ....
- 22 Aug · Meeting
  Dear Sir/Madam, This is to inform that 33rd Annual General Meeting ('AGM') of the Company was conducted on August 20, 2022 at 12:00 P.M. through Video Conferencing ('VC') and/or Other .... (opens in a new tab)
- 20 Aug · Meeting
  Proceedings of 33rd AGM (opens in a new tab)
- 9 Aug · SDD Compliance Certificate For The Quarter Ended June 30, 2022
  Dear Sir/Madam, Pursuant to Regulation 3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations), please find enclosed .... (opens in a new tab)
- 4 Aug · Management
  Dear Sir / Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part .... (opens in a new tab)
Jul 2022
- 23 Jul · Reg. 34 (1) Annual Report.
  Dear Sir/Madam, Pursuant to Regulation 34 of SEBI (LODR) Regulations, 2015, please find enclosed the Notice convening the 33rd Annual General Meeting (AGM) of shareholders and the Annual .... (opens in a new tab)
- 22 Jul · Meeting
  Dear Sir/ Madam, Please find the attached Outcome of Board Meeting regarding approval of Un Audited Financial Statements for the Quarter ended 30.06.2022 along With Limited Review .... (opens in a new tab)
- 14 Jul · Board meeting
  Meeting on 22 Jul 2022: quarterly results and annual general meeting
- 14 Jul · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2022 ,inter alia, to consider and approve 1. Unaudited Financial .... (opens in a new tab)
- 9 Jul · Board meeting
  Dear Sir/Madam, Please find attached the outcome of the Board Meeting regarding Appointment and Resignation of the Directors. This is for your information and dissemination. Regards For .... (opens in a new tab)
- 6 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
- 6 Jun · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sadhanala Venkata Rao (opens in a new tab)
- 2 Jun · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sadhanala Venkata Rao (opens in a new tab)
- 2 Jun · Revised Compliance Certificate For Regulation 40(10) For The Year Ended March, 2022.
  Dear Sir/Madam, Please find attached revised Compliance Certificate of Regulation 40(10) certified by the Company Secretary for the year ended 31st March 2022. This is for your information. For .... (opens in a new tab)
May 2022
- 31 May · Submission Of Half Yearly Disclosure On Related Party Transactions
  Dear Sir, Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, we enclose herewith disclosure on Related Party Transactions, .... (opens in a new tab)
- 21 May · Results
  Dear Sir/ Madam, Please find the attached Audited Financial results along with the Outcome of Board Meeting and Audit Report for the Quarter and Year ended March 31, 2022. .... (opens in a new tab)
- 21 May · Results
  Dear Sir/ Madam, Please find the attached Audited Financial results along with the Outcome of Board Meeting and Audit Report for the Quarter and Year ended March 31, 2022. .... (opens in a new tab)